Arteriosclerosis, Bone Biology, and Calciotropic Hormone Signaling: Learning the ABCs of Disease in the Bone-vascular Axis
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Xu Z, Liu X, Li Y, Gao H, He T, Zhang C Exp Ther Med. 2021; 21(3):197.
PMID: 33488806 PMC: 7812579. DOI: 10.3892/etm.2021.9630.
Magnesium and cardiovascular complications of chronic kidney disease.
Massy Z, Drueke T Nat Rev Nephrol. 2015; 11(7):432-42.
PMID: 25963594 DOI: 10.1038/nrneph.2015.74.
References
1.
Yuan Q, Sato T, Densmore M, Saito H, Schuler C, Erben R
. FGF-23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH. J Bone Miner Res. 2011; 26(9):2026-35.
PMC: 4343543.
DOI: 10.1002/jbmr.433.
View
2.
Iwasaki Y, Yamato H, Nii-Kono T, Fujieda A, Uchida M, Hosokawa A
. Insufficiency of PTH action on bone in uremia. Kidney Int Suppl. 2006; (102):S34-6.
DOI: 10.1038/sj.ki.5001600.
View
3.
Lilly S, Qasim A, Mulvey C, Churchill T, Reilly M, Eraso L
. Non-compressible arterial disease and the risk of coronary calcification in type-2 diabetes. Atherosclerosis. 2013; 230(1):17-22.
DOI: 10.1016/j.atherosclerosis.2013.06.004.
View
4.
Raison D, Coquard C, Hochane M, Steger J, Massfelder T, Moulin B
. Knockdown of parathyroid hormone related protein in smooth muscle cells alters renal hemodynamics but not blood pressure. Am J Physiol Renal Physiol. 2013; 305(3):F333-42.
DOI: 10.1152/ajprenal.00503.2012.
View
5.
London G, Marty C, Marchais S, Guerin A, Metivier F, de Vernejoul M
. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol. 2004; 15(7):1943-51.
DOI: 10.1097/01.asn.0000129337.50739.48.
View